Physician profile
Nancy Koh
NPI 1942547971
$1,020.00
in general payments reported to CMS, 2019-2025
10 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $425 · 2023: $140 · 2024: $122 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $152.54 | 2022-2025 | Enhertu |
| Secura Bio, INC. | $151.70 | 2022 | |
| Stemline Therapeutics INC. | $125.00 | 2023 | Orserdu |
| Amgen INC. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $124.77 | 2022 | |
| Janssen Biotech, INC. | $121.84 | 2024 | Tecvayli, Darzalex |
| Pfizer INC. | $116.87 | 2025 | |
| Genentech USA, INC. | $62.04 | 2025 | Phesgo, Ocrevus Zunovo |
| Geron Corporation | $25.04 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $15.20 | 2023 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Koh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.